292 related articles for article (PubMed ID: 1281632)
1. Group A streptococcal M proteins: virulence factors and protective antigens.
Robinson JH; Kehoe MA
Immunol Today; 1992 Sep; 13(9):362-7. PubMed ID: 1281632
[TBL] [Abstract][Full Text] [Related]
2. [Molecular structure and immunochemistry of streptococcal M-protein].
Ookuni H
Tanpakushitsu Kakusan Koso; 1990 Nov; 35(15):2839-51. PubMed ID: 1701908
[No Abstract] [Full Text] [Related]
3. Group A streptococcal antigens and vaccine potential.
Kehoe MA
Vaccine; 1991 Nov; 9(11):797-806. PubMed ID: 1722063
[TBL] [Abstract][Full Text] [Related]
4. Epitopes of group A streptococcal M protein that evoke cross-protective local immune responses.
Bronze MS; Courtney HS; Dale JB
J Immunol; 1992 Feb; 148(3):888-93. PubMed ID: 1370521
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis of group A streptococci in mice and efficacy of locally administered streptococcal vaccines.
Bronze MS; McKinsey DS; Beachey EH; Dale JB
Trans Assoc Am Physicians; 1988; 101():88-92. PubMed ID: 3077732
[No Abstract] [Full Text] [Related]
6. Processing of viable group A streptococci leads to major histocompatibility complex class II presentation of T cell epitopes from the major protective antigen.
Rossiter BA; Alfonso C; Kehoe MA; Robinson JH
Eur J Immunol; 1994 May; 24(5):1244-7. PubMed ID: 7514136
[TBL] [Abstract][Full Text] [Related]
7. Streptococcal M protein.
Fischetti VA
Sci Am; 1991 Jun; 264(6):58-65. PubMed ID: 1857955
[No Abstract] [Full Text] [Related]
8. Recombinant tetravalent group A streptococcal M protein vaccine.
Dale JB; Chiang EY; Lederer JW
J Immunol; 1993 Aug; 151(4):2188-94. PubMed ID: 8345202
[TBL] [Abstract][Full Text] [Related]
9. [Mechanisms and manifestations of population variability in Streptococcus pyogenes].
Kaminskiĭ GD; Beliakov VD
Vestn Akad Med Nauk SSSR; 1986; (7):10-7. PubMed ID: 2428180
[No Abstract] [Full Text] [Related]
10. Streptococcal defenses against host immune attack: the M protein-fibrinogen interaction.
Whitnack E; Dale JB; Beachey EH
Trans Assoc Am Physicians; 1983; 96():197-202. PubMed ID: 6208666
[No Abstract] [Full Text] [Related]
11. New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population.
Brandt ER; Sriprakash KS; Hobb RI; Hayman WA; Zeng W; Batzloff MR; Jackson DC; Good MF
Nat Med; 2000 Apr; 6(4):455-9. PubMed ID: 10742155
[TBL] [Abstract][Full Text] [Related]
12. Variation of multifunctional surface binding proteins--a virulence strategy for group A streptococci?
Boyle MD
J Theor Biol; 1995 Apr; 173(4):415-26. PubMed ID: 7783451
[TBL] [Abstract][Full Text] [Related]
13. Cross-reactivity between streptococcus and human tissue: a model of molecular mimicry and autoimmunity.
Froude J; Gibofsky A; Buskirk DR; Khanna A; Zabriskie JB
Curr Top Microbiol Immunol; 1989; 145():5-26. PubMed ID: 2680297
[No Abstract] [Full Text] [Related]
14. The quest for GAS vaccine.
Pandey M; Good MF
Oncotarget; 2015 Oct; 6(33):34063-4. PubMed ID: 26485764
[No Abstract] [Full Text] [Related]
15. Structural optimisation of a conformational epitope improves antigenicity when expressed as a recombinant fusion protein.
Georgousakis MM; Hofmann A; Batzloff MR; McMillan DJ; Sriprakash KS
Vaccine; 2009 Nov; 27(48):6799-806. PubMed ID: 19729086
[TBL] [Abstract][Full Text] [Related]
16. Synthetic peptide vaccine against mucosal colonization by group A streptococci. I. Protection against a heterologous M serotype with shared C repeat region epitopes.
Bessen D; Fischetti VA
J Immunol; 1990 Aug; 145(4):1251-6. PubMed ID: 1696296
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of novel Streptococcus pyogenes vaccine candidates incorporating multiple conserved sequences from the C-repeat region of the M-protein.
Bauer MJ; Georgousakis MM; Vu T; Henningham A; Hofmann A; Rettel M; Hafner LM; Sriprakash KS; McMillan DJ
Vaccine; 2012 Mar; 30(12):2197-205. PubMed ID: 22265945
[TBL] [Abstract][Full Text] [Related]
18. Bactericidal activity of M protein conserved region antibodies against group A streptococcal isolates from the Northern Thai population.
Yoonim N; Olive C; Pruksachatkunakorn C; Pruksakorn S
BMC Microbiol; 2006 Aug; 6():71. PubMed ID: 16895610
[TBL] [Abstract][Full Text] [Related]
19. Prospects for a group A streptococcal vaccine.
McMillan DJ; Chhatwal GS
Curr Opin Mol Ther; 2005 Feb; 7(1):11-6. PubMed ID: 15732524
[TBL] [Abstract][Full Text] [Related]
20. Lipid core peptide technology and group A streptococcal vaccine delivery.
Olive C; Batzloff MR; Toth I
Expert Rev Vaccines; 2004 Feb; 3(1):43-58. PubMed ID: 14761243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
